alpha-Glucosidase inhibitor acarbose and sequestome 1/A170/p62 deficient mice: A promising therapy and unique model for non-alcoholic fatty liver disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples